 | • レポートコード：GIR-23F3943 • 出版社/出版日：GlobalInfoResearch / 2023年2月 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Swine Influenza Vaccines Market」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社（香港）の最新の調査によると、世界の豚インフルエンザワクチンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 豚インフルエンザワクチン市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次を対象にします。 ・生ワクチン、不活化ワクチン アプリケーション別セグメントは次のように区分されます。 ・商品豚、繁殖豚 世界の豚インフルエンザワクチン市場の主要なマーケットプレーヤーは以下のとおりです。 ・Chengdu TECBOND、Green Cross Veterinary、Hipra、MSD Animal Health (Merck)、Zoetis、CAHIC、Merial、Ceva、Ringpu Biology、DHN 地域別セグメントは次の地域・国を対象にします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） ***** 目次(一部) ***** ・市場概要 - 豚インフルエンザワクチンの概要 - タイプ別分析（2017年vs2021年vs2028年）：生ワクチン、不活化ワクチン - アプリケーション別分析（2017年vs2021年vs2028年）：商品豚、繁殖豚 - 世界の豚インフルエンザワクチン市場規模・予測 - 世界の豚インフルエンザワクチン生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Chengdu TECBOND、Green Cross Veterinary、Hipra、MSD Animal Health (Merck)、Zoetis、CAHIC、Merial、Ceva、Ringpu Biology、DHN ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：生ワクチン、不活化ワクチン ・アプリケーション別分析2017年-2028年：商品豚、繁殖豚 ・豚インフルエンザワクチンの北米市場分析 - 豚インフルエンザワクチンの北米市場：タイプ別市場規模2017年-2028年 - 豚インフルエンザワクチンの北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・豚インフルエンザワクチンのヨーロッパ市場分析 - ：豚インフルエンザワクチンのヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：豚インフルエンザワクチンのヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・豚インフルエンザワクチンのアジア太平洋市場分析 - 豚インフルエンザワクチンのアジア太平洋市場：タイプ別市場規模2017年-2028年 - 豚インフルエンザワクチンのアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・豚インフルエンザワクチンの南米市場分析 - 豚インフルエンザワクチンの南米市場：タイプ別市場規模2017年-2028年 - 豚インフルエンザワクチンの南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・豚インフルエンザワクチンの中東・アフリカ市場分析 - 豚インフルエンザワクチンの中東・アフリカ市場：タイプ別市場規模2017年-2028年 - 豚インフルエンザワクチンの中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Swine Influenza Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Swine Influenza Vaccines market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Commodity Pig accounting for % of the Swine Influenza Vaccines global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Live Vaccines segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Swine Influenza Vaccines include Chengdu TECBOND, Green Cross Veterinary, Hipra, MSD Animal Health (Merck), and Zoetis, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Swine Influenza Vaccines market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Live Vaccines
Killed Vaccines
Market segment by Application can be divided into
Commodity Pig
Breeding Pig
The key market players for global Swine Influenza Vaccines market are listed below:
Chengdu TECBOND
Green Cross Veterinary
Hipra
MSD Animal Health (Merck)
Zoetis
CAHIC
Merial
Ceva
Ringpu Biology
DHN
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Swine Influenza Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Swine Influenza Vaccines, with price, sales, revenue and global market share of Swine Influenza Vaccines from 2019 to 2022.
Chapter 3, the Swine Influenza Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Swine Influenza Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Swine Influenza Vaccines market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Swine Influenza Vaccines.
Chapter 13, 14, and 15, to describe Swine Influenza Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Swine Influenza Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Swine Influenza Vaccines Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Live Vaccines
1.2.3 Killed Vaccines
1.3 Market Analysis by Application
1.3.1 Overview: Global Swine Influenza Vaccines Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Commodity Pig
1.3.3 Breeding Pig
1.4 Global Swine Influenza Vaccines Market Size & Forecast
1.4.1 Global Swine Influenza Vaccines Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Swine Influenza Vaccines Sales in Volume (2017-2028)
1.4.3 Global Swine Influenza Vaccines Price (2017-2028)
1.5 Global Swine Influenza Vaccines Production Capacity Analysis
1.5.1 Global Swine Influenza Vaccines Total Production Capacity (2017-2028)
1.5.2 Global Swine Influenza Vaccines Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Swine Influenza Vaccines Market Drivers
1.6.2 Swine Influenza Vaccines Market Restraints
1.6.3 Swine Influenza Vaccines Trends Analysis
2 Manufacturers Profiles
2.1 Chengdu TECBOND
2.1.1 Chengdu TECBOND Details
2.1.2 Chengdu TECBOND Major Business
2.1.3 Chengdu TECBOND Swine Influenza Vaccines Product and Services
2.1.4 Chengdu TECBOND Swine Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Green Cross Veterinary
2.2.1 Green Cross Veterinary Details
2.2.2 Green Cross Veterinary Major Business
2.2.3 Green Cross Veterinary Swine Influenza Vaccines Product and Services
2.2.4 Green Cross Veterinary Swine Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Hipra
2.3.1 Hipra Details
2.3.2 Hipra Major Business
2.3.3 Hipra Swine Influenza Vaccines Product and Services
2.3.4 Hipra Swine Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 MSD Animal Health (Merck)
2.4.1 MSD Animal Health (Merck) Details
2.4.2 MSD Animal Health (Merck) Major Business
2.4.3 MSD Animal Health (Merck) Swine Influenza Vaccines Product and Services
2.4.4 MSD Animal Health (Merck) Swine Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Zoetis
2.5.1 Zoetis Details
2.5.2 Zoetis Major Business
2.5.3 Zoetis Swine Influenza Vaccines Product and Services
2.5.4 Zoetis Swine Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 CAHIC
2.6.1 CAHIC Details
2.6.2 CAHIC Major Business
2.6.3 CAHIC Swine Influenza Vaccines Product and Services
2.6.4 CAHIC Swine Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Merial
2.7.1 Merial Details
2.7.2 Merial Major Business
2.7.3 Merial Swine Influenza Vaccines Product and Services
2.7.4 Merial Swine Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Ceva
2.8.1 Ceva Details
2.8.2 Ceva Major Business
2.8.3 Ceva Swine Influenza Vaccines Product and Services
2.8.4 Ceva Swine Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Ringpu Biology
2.9.1 Ringpu Biology Details
2.9.2 Ringpu Biology Major Business
2.9.3 Ringpu Biology Swine Influenza Vaccines Product and Services
2.9.4 Ringpu Biology Swine Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 DHN
2.10.1 DHN Details
2.10.2 DHN Major Business
2.10.3 DHN Swine Influenza Vaccines Product and Services
2.10.4 DHN Swine Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Swine Influenza Vaccines Breakdown Data by Manufacturer
3.1 Global Swine Influenza Vaccines Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Swine Influenza Vaccines Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Swine Influenza Vaccines
3.4 Market Concentration Rate
3.4.1 Top 3 Swine Influenza Vaccines Manufacturer Market Share in 2021
3.4.2 Top 6 Swine Influenza Vaccines Manufacturer Market Share in 2021
3.5 Global Swine Influenza Vaccines Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Swine Influenza Vaccines Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Swine Influenza Vaccines Market Size by Region
4.1.1 Global Swine Influenza Vaccines Sales in Volume by Region (2017-2028)
4.1.2 Global Swine Influenza Vaccines Revenue by Region (2017-2028)
4.2 North America Swine Influenza Vaccines Revenue (2017-2028)
4.3 Europe Swine Influenza Vaccines Revenue (2017-2028)
4.4 Asia-Pacific Swine Influenza Vaccines Revenue (2017-2028)
4.5 South America Swine Influenza Vaccines Revenue (2017-2028)
4.6 Middle East and Africa Swine Influenza Vaccines Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Swine Influenza Vaccines Sales in Volume by Type (2017-2028)
5.2 Global Swine Influenza Vaccines Revenue by Type (2017-2028)
5.3 Global Swine Influenza Vaccines Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Swine Influenza Vaccines Sales in Volume by Application (2017-2028)
6.2 Global Swine Influenza Vaccines Revenue by Application (2017-2028)
6.3 Global Swine Influenza Vaccines Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Swine Influenza Vaccines Sales by Type (2017-2028)
7.2 North America Swine Influenza Vaccines Sales by Application (2017-2028)
7.3 North America Swine Influenza Vaccines Market Size by Country
7.3.1 North America Swine Influenza Vaccines Sales in Volume by Country (2017-2028)
7.3.2 North America Swine Influenza Vaccines Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Swine Influenza Vaccines Sales by Type (2017-2028)
8.2 Europe Swine Influenza Vaccines Sales by Application (2017-2028)
8.3 Europe Swine Influenza Vaccines Market Size by Country
8.3.1 Europe Swine Influenza Vaccines Sales in Volume by Country (2017-2028)
8.3.2 Europe Swine Influenza Vaccines Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Swine Influenza Vaccines Sales by Type (2017-2028)
9.2 Asia-Pacific Swine Influenza Vaccines Sales by Application (2017-2028)
9.3 Asia-Pacific Swine Influenza Vaccines Market Size by Region
9.3.1 Asia-Pacific Swine Influenza Vaccines Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Swine Influenza Vaccines Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Swine Influenza Vaccines Sales by Type (2017-2028)
10.2 South America Swine Influenza Vaccines Sales by Application (2017-2028)
10.3 South America Swine Influenza Vaccines Market Size by Country
10.3.1 South America Swine Influenza Vaccines Sales in Volume by Country (2017-2028)
10.3.2 South America Swine Influenza Vaccines Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Swine Influenza Vaccines Sales by Type (2017-2028)
11.2 Middle East & Africa Swine Influenza Vaccines Sales by Application (2017-2028)
11.3 Middle East & Africa Swine Influenza Vaccines Market Size by Country
11.3.1 Middle East & Africa Swine Influenza Vaccines Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Swine Influenza Vaccines Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Swine Influenza Vaccines and Key Manufacturers
12.2 Manufacturing Costs Percentage of Swine Influenza Vaccines
12.3 Swine Influenza Vaccines Production Process
12.4 Swine Influenza Vaccines Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Swine Influenza Vaccines Typical Distributors
13.3 Swine Influenza Vaccines Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
Table 1. Global Swine Influenza Vaccines Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Swine Influenza Vaccines Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Chengdu TECBOND Basic Information, Manufacturing Base and Competitors
Table 4. Chengdu TECBOND Major Business
Table 5. Chengdu TECBOND Swine Influenza Vaccines Product and Services
Table 6. Chengdu TECBOND Swine Influenza Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Green Cross Veterinary Basic Information, Manufacturing Base and Competitors
Table 8. Green Cross Veterinary Major Business
Table 9. Green Cross Veterinary Swine Influenza Vaccines Product and Services
Table 10. Green Cross Veterinary Swine Influenza Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Hipra Basic Information, Manufacturing Base and Competitors
Table 12. Hipra Major Business
Table 13. Hipra Swine Influenza Vaccines Product and Services
Table 14. Hipra Swine Influenza Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. MSD Animal Health (Merck) Basic Information, Manufacturing Base and Competitors
Table 16. MSD Animal Health (Merck) Major Business
Table 17. MSD Animal Health (Merck) Swine Influenza Vaccines Product and Services
Table 18. MSD Animal Health (Merck) Swine Influenza Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Zoetis Basic Information, Manufacturing Base and Competitors
Table 20. Zoetis Major Business
Table 21. Zoetis Swine Influenza Vaccines Product and Services
Table 22. Zoetis Swine Influenza Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. CAHIC Basic Information, Manufacturing Base and Competitors
Table 24. CAHIC Major Business
Table 25. CAHIC Swine Influenza Vaccines Product and Services
Table 26. CAHIC Swine Influenza Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Merial Basic Information, Manufacturing Base and Competitors
Table 28. Merial Major Business
Table 29. Merial Swine Influenza Vaccines Product and Services
Table 30. Merial Swine Influenza Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Ceva Basic Information, Manufacturing Base and Competitors
Table 32. Ceva Major Business
Table 33. Ceva Swine Influenza Vaccines Product and Services
Table 34. Ceva Swine Influenza Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Ringpu Biology Basic Information, Manufacturing Base and Competitors
Table 36. Ringpu Biology Major Business
Table 37. Ringpu Biology Swine Influenza Vaccines Product and Services
Table 38. Ringpu Biology Swine Influenza Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. DHN Basic Information, Manufacturing Base and Competitors
Table 40. DHN Major Business
Table 41. DHN Swine Influenza Vaccines Product and Services
Table 42. DHN Swine Influenza Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Global Swine Influenza Vaccines Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 44. Global Swine Influenza Vaccines Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 45. Market Position of Manufacturers in Swine Influenza Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 46. Global Swine Influenza Vaccines Production Capacity by Company, (K Units): 2020 VS 2021
Table 47. Head Office and Swine Influenza Vaccines Production Site of Key Manufacturer
Table 48. Swine Influenza Vaccines New Entrant and Capacity Expansion Plans
Table 49. Swine Influenza Vaccines Mergers & Acquisitions in the Past Five Years
Table 50. Global Swine Influenza Vaccines Sales by Region (2017-2022) & (K Units)
Table 51. Global Swine Influenza Vaccines Sales by Region (2023-2028) & (K Units)
Table 52. Global Swine Influenza Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 53. Global Swine Influenza Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 54. Global Swine Influenza Vaccines Sales by Type (2017-2022) & (K Units)
Table 55. Global Swine Influenza Vaccines Sales by Type (2023-2028) & (K Units)
Table 56. Global Swine Influenza Vaccines Revenue by Type (2017-2022) & (USD Million)
Table 57. Global Swine Influenza Vaccines Revenue by Type (2023-2028) & (USD Million)
Table 58. Global Swine Influenza Vaccines Price by Type (2017-2022) & (USD/Unit)
Table 59. Global Swine Influenza Vaccines Price by Type (2023-2028) & (USD/Unit)
Table 60. Global Swine Influenza Vaccines Sales by Application (2017-2022) & (K Units)
Table 61. Global Swine Influenza Vaccines Sales by Application (2023-2028) & (K Units)
Table 62. Global Swine Influenza Vaccines Revenue by Application (2017-2022) & (USD Million)
Table 63. Global Swine Influenza Vaccines Revenue by Application (2023-2028) & (USD Million)
Table 64. Global Swine Influenza Vaccines Price by Application (2017-2022) & (USD/Unit)
Table 65. Global Swine Influenza Vaccines Price by Application (2023-2028) & (USD/Unit)
Table 66. North America Swine Influenza Vaccines Sales by Country (2017-2022) & (K Units)
Table 67. North America Swine Influenza Vaccines Sales by Country (2023-2028) & (K Units)
Table 68. North America Swine Influenza Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 69. North America Swine Influenza Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 70. North America Swine Influenza Vaccines Sales by Type (2017-2022) & (K Units)
Table 71. North America Swine Influenza Vaccines Sales by Type (2023-2028) & (K Units)
Table 72. North America Swine Influenza Vaccines Sales by Application (2017-2022) & (K Units)
Table 73. North America Swine Influenza Vaccines Sales by Application (2023-2028) & (K Units)
Table 74. Europe Swine Influenza Vaccines Sales by Country (2017-2022) & (K Units)
Table 75. Europe Swine Influenza Vaccines Sales by Country (2023-2028) & (K Units)
Table 76. Europe Swine Influenza Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 77. Europe Swine Influenza Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 78. Europe Swine Influenza Vaccines Sales by Type (2017-2022) & (K Units)
Table 79. Europe Swine Influenza Vaccines Sales by Type (2023-2028) & (K Units)
Table 80. Europe Swine Influenza Vaccines Sales by Application (2017-2022) & (K Units)
Table 81. Europe Swine Influenza Vaccines Sales by Application (2023-2028) & (K Units)
Table 82. Asia-Pacific Swine Influenza Vaccines Sales by Region (2017-2022) & (K Units)
Table 83. Asia-Pacific Swine Influenza Vaccines Sales by Region (2023-2028) & (K Units)
Table 84. Asia-Pacific Swine Influenza Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 85. Asia-Pacific Swine Influenza Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 86. Asia-Pacific Swine Influenza Vaccines Sales by Type (2017-2022) & (K Units)
Table 87. Asia-Pacific Swine Influenza Vaccines Sales by Type (2023-2028) & (K Units)
Table 88. Asia-Pacific Swine Influenza Vaccines Sales by Application (2017-2022) & (K Units)
Table 89. Asia-Pacific Swine Influenza Vaccines Sales by Application (2023-2028) & (K Units)
Table 90. South America Swine Influenza Vaccines Sales by Country (2017-2022) & (K Units)
Table 91. South America Swine Influenza Vaccines Sales by Country (2023-2028) & (K Units)
Table 92. South America Swine Influenza Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 93. South America Swine Influenza Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 94. South America Swine Influenza Vaccines Sales by Type (2017-2022) & (K Units)
Table 95. South America Swine Influenza Vaccines Sales by Type (2023-2028) & (K Units)
Table 96. South America Swine Influenza Vaccines Sales by Application (2017-2022) & (K Units)
Table 97. South America Swine Influenza Vaccines Sales by Application (2023-2028) & (K Units)
Table 98. Middle East & Africa Swine Influenza Vaccines Sales by Region (2017-2022) & (K Units)
Table 99. Middle East & Africa Swine Influenza Vaccines Sales by Region (2023-2028) & (K Units)
Table 100. Middle East & Africa Swine Influenza Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 101. Middle East & Africa Swine Influenza Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 102. Middle East & Africa Swine Influenza Vaccines Sales by Type (2017-2022) & (K Units)
Table 103. Middle East & Africa Swine Influenza Vaccines Sales by Type (2023-2028) & (K Units)
Table 104. Middle East & Africa Swine Influenza Vaccines Sales by Application (2017-2022) & (K Units)
Table 105. Middle East & Africa Swine Influenza Vaccines Sales by Application (2023-2028) & (K Units)
Table 106. Swine Influenza Vaccines Raw Material
Table 107. Key Manufacturers of Swine Influenza Vaccines Raw Materials
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Swine Influenza Vaccines Typical Distributors
Table 111. Swine Influenza Vaccines Typical Customers
List of Figures
Figure 1. Swine Influenza Vaccines Picture
Figure 2. Global Swine Influenza Vaccines Revenue Market Share by Type in 2021
Figure 3. Live Vaccines
Figure 4. Killed Vaccines
Figure 5. Global Swine Influenza Vaccines Revenue Market Share by Application in 2021
Figure 6. Commodity Pig
Figure 7. Breeding Pig
Figure 8. Global Swine Influenza Vaccines Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 9. Global Swine Influenza Vaccines Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Swine Influenza Vaccines Sales (2017-2028) & (K Units)
Figure 11. Global Swine Influenza Vaccines Price (2017-2028) & (USD/Unit)
Figure 12. Global Swine Influenza Vaccines Production Capacity (2017-2028) & (K Units)
Figure 13. Global Swine Influenza Vaccines Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Swine Influenza Vaccines Market Drivers
Figure 15. Swine Influenza Vaccines Market Restraints
Figure 16. Swine Influenza Vaccines Market Trends
Figure 17. Global Swine Influenza Vaccines Sales Market Share by Manufacturer in 2021
Figure 18. Global Swine Influenza Vaccines Revenue Market Share by Manufacturer in 2021
Figure 19. Swine Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Swine Influenza Vaccines Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Swine Influenza Vaccines Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Swine Influenza Vaccines Sales Market Share by Region (2017-2028)
Figure 23. Global Swine Influenza Vaccines Revenue Market Share by Region (2017-2028)
Figure 24. North America Swine Influenza Vaccines Revenue (2017-2028) & (USD Million)
Figure 25. Europe Swine Influenza Vaccines Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Swine Influenza Vaccines Revenue (2017-2028) & (USD Million)
Figure 27. South America Swine Influenza Vaccines Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Swine Influenza Vaccines Revenue (2017-2028) & (USD Million)
Figure 29. Global Swine Influenza Vaccines Sales Market Share by Type (2017-2028)
Figure 30. Global Swine Influenza Vaccines Revenue Market Share by Type (2017-2028)
Figure 31. Global Swine Influenza Vaccines Price by Type (2017-2028) & (USD/Unit)
Figure 32. Global Swine Influenza Vaccines Sales Market Share by Application (2017-2028)
Figure 33. Global Swine Influenza Vaccines Revenue Market Share by Application (2017-2028)
Figure 34. Global Swine Influenza Vaccines Price by Application (2017-2028) & (USD/Unit)
Figure 35. North America Swine Influenza Vaccines Sales Market Share by Type (2017-2028)
Figure 36. North America Swine Influenza Vaccines Sales Market Share by Application (2017-2028)
Figure 37. North America Swine Influenza Vaccines Sales Market Share by Country (2017-2028)
Figure 38. North America Swine Influenza Vaccines Revenue Market Share by Country (2017-2028)
Figure 39. United States Swine Influenza Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Swine Influenza Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Swine Influenza Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Swine Influenza Vaccines Sales Market Share by Type (2017-2028)
Figure 43. Europe Swine Influenza Vaccines Sales Market Share by Application (2017-2028)
Figure 44. Europe Swine Influenza Vaccines Sales Market Share by Country (2017-2028)
Figure 45. Europe Swine Influenza Vaccines Revenue Market Share by Country (2017-2028)
Figure 46. Germany Swine Influenza Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Swine Influenza Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Swine Influenza Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Swine Influenza Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Swine Influenza Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Swine Influenza Vaccines Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Swine Influenza Vaccines Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Swine Influenza Vaccines Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Swine Influenza Vaccines Revenue Market Share by Region (2017-2028)
Figure 55. China Swine Influenza Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Swine Influenza Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Swine Influenza Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Swine Influenza Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Swine Influenza Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Swine Influenza Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Swine Influenza Vaccines Sales Market Share by Type (2017-2028)
Figure 62. South America Swine Influenza Vaccines Sales Market Share by Application (2017-2028)
Figure 63. South America Swine Influenza Vaccines Sales Market Share by Country (2017-2028)
Figure 64. South America Swine Influenza Vaccines Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Swine Influenza Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Swine Influenza Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Swine Influenza Vaccines Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Swine Influenza Vaccines Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Swine Influenza Vaccines Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Swine Influenza Vaccines Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Swine Influenza Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Swine Influenza Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Swine Influenza Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Swine Influenza Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Swine Influenza Vaccines in 2021
Figure 76. Manufacturing Process Analysis of Swine Influenza Vaccines
Figure 77. Swine Influenza Vaccines Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source